Om Megashree Pharmaceuticals Closing IPO to General Public from Today
March 16, 2025 | Investopaper
After the first phase, Om Megashree Pharmaceuticals Limited is currently issuing the shares to the general public in the second phase of an initial public offering (IPO) from Falgun 27, 2081 BS.
The company is selling 14,76,000 shares at Rs. 100 per share to the general public.
Due to over-subscription of shares, the second phase of the IPO will close on Chaitra 3, 2081 BS.
Interested investors can apply for a minimum of 10 shares and a maximum of 10,000 shares.
The company has allotted 90,000 shares to the mutual fund schemes and has reserved 54,000 shares to the employees.
First Phase: IPO To Foreign Employed Nepalis
In the first phase of the IPO, the company had floated 1,80,000 shares (10 percent of general public’s quota) to the foreign employed Nepalis from Magh 21, 2081 BS. The first phase of the IPO was closed on Falgun 5, 2081 BS.
Interested Nepalis in foreign employment could apply for a minimum of 10 shares and a maximum of 10,000 shares.
For this purpose, Securities Board of Nepal (SEBON) had given the approval to the company on Magh 3, 2081 BS.
In total, the company has plans to sell 18,00,000 unit shares in the public offering (including the first and the second phase). At a par value of Rs 100, the public issue amounts to Rs 18 crores.
As of Poush’s end 2081 BS, Om Megashree Pharmaceuticals Limited has a paid-up capital of Rs. 42 crores. After the IPO (if fully subscribed), the capital will increase to Rs. 60 crores.
The company had appointed Prabhu Capital Limited as issue and sales manager. The agreement for public offering was inked by Mr. Arjun Kumar Shrestha, Chairman of Om Megashree Pharmaceuticals and Mr. Dinesh Thakali, Managing Director of Prabhu Capital Limited.
Om Megashree Pharmaceuticals Limited was registered in 2017. The manufacturing plant is located at Jugedi-29, Bharatpur, Chitwan.
Recommended:
